Jason Lettmann, CEO, Director at ALX Oncology Holdings, holds 171.62K shares in ALX Oncology Holdings (Ticker: ALXO). Most recently, Jason Lettmann Bought $4,400 shares of ALX Oncology Holdings on Mar 18, 2024 for an estimated value of 49.76K.
What is the percentage of profitable transactions made by Jason Lettmann?
The percentage of profitable transactions made by Jason Lettmann is 100%.
What is the average return per transaction made by Jason Lettmann?
The average return per transaction made by Jason Lettmann is 66.50%.
What stocks does Jason Lettmann hold?
Jason Lettmann holds: ALXO stocks.
What was Jason Lettmann’s latest transaction?
Jason Lettmann latest transaction was an Informative Buy of $49.76K.
What was Jason Lettmann's most profitable transaction?
Jason Lettmann’s most profitable transaction was an Informative Buy of ALXO stock on July 21, 2020. The return on the trade was 89.70%.
What is Jason Lettmann's role in ALX Oncology Holdings?
Jason Lettmann's role in ALX Oncology Holdings is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.